Safety and Efficacy of a Three-Dose Regimen of an Adenoviral HIV Vaccine (MRKAd5 HIV-1 Gag/Pol/Nef) in HIV Uninfected South African Adults

This study has suspended participant recruitment.

Sponsor:

Collaborator:

HIV Vaccine Trials Network

Information provided by (Responsible Party):

National Institute of Allergy and Infectious Diseases (NIAID)

ClinicalTrials.gov Identifier:

NCT00413725

First received: December 18, 2006

Last updated: April 8, 2013

Last verified: April 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has suspended participant recruitment.
Estimated Study Completion Date:	No date given
Primary Completion Date:	August 2012 (Final data collection date for primary outcome measure)

Publications:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):